NCT03444714 2025-09-15
Phase I Study of RiMO-301 With Radiation in Advanced Tumors
Coordination Pharmaceuticals, Inc.
Phase 1 Completed
Coordination Pharmaceuticals, Inc.
Hutchmed
Coordination Pharmaceuticals, Inc.
Coordination Pharmaceuticals, Inc.
Bristol-Myers Squibb